In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.

The US Food and Drug Administration (FDA) has expanded the indication for the MitraClip (Abbott) device to include patients with normal mitral valves who develop symptoms of heart failure and moderate ...

Cardiovascular diseases or heart problems are still one of the leading causes of death across the globe, and these include such conditions as coronary artery diseases, hypertension, stroke, and many ...

In COAPT, the MitraClip performed far better than known winners in cardiology, such as percutaneous coronary intervention (PCI) for acute myocardial infarction or implantable ...

Navi Mumbai: A 78-year-old patient with severe mitral regurgitation has successfully undergone the MitraClip procedure, ...